Connection
Thomas Meyer to Survival Analysis
This is a "connection" page, showing publications Thomas Meyer has written about Survival Analysis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.084 |
|
|
|
-
Dabrow MB, Francesco MR, Gilman PB, Cantor R, Rose L, Meyer TJ. Combined therapy with topotecan and gemcitabine in patients with inoperable or metastatic non-small cell lung cancer. Cancer Invest. 2003; 21(4):517-25.
Score: 0.041
-
Shen X, Denittis A, Werner-Wasik M, Axelrod R, Gilman P, Meyer T, Treat J, Curran WJ, Machtay M. Phase i study of 'dose-dense' pemetrexed plus carboplatin/radiotherapy for locally advanced non-small cell lung carcinoma. Radiat Oncol. 2011 Feb 16; 6:17.
Score: 0.018
-
Brunner TB, Tinkl D, Grabenbauer GG, Meyer T, Brueckl WM, Sauer R. Maintenance chemotherapy after chemoradiation improves survival of patients with locally advanced pancreatic carcinoma: a retrospective analysis of prospectively recruited patients. Strahlenther Onkol. 2006 Apr; 182(4):210-5.
Score: 0.013
-
Brunner TB, Schwab D, Meyer T, Sauer R. Chemoradiation may prolong survival of patients with non-bulky unresectable extrahepatic biliary carcinoma. A retrospective analysis. Strahlenther Onkol. 2004 Dec; 180(12):751-7.
Score: 0.012